Research programme: contraceptive sprays - Acrux/Organon
Latest Information Update: 14 Aug 2008
At a glance
- Originator Acrux; Organon
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 14 Aug 2008 Preclinical development is ongoing
- 12 Aug 2008 KV Pharmaceutical Company licenses MDTS technology from Acrux in the USA
- 19 Nov 2007 Organon has been acquired by Schering-Plough